TYRA NEWTON: Open Payments
NPI 1043637598 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 11 payments from 9 companies in 2025. Trend: 2023 $773 · 2024 $759 · 2025 $1,206
Food & beverage: $1,206
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $247 |
| Lilly USA, LLC | 2 | $208 |
| Otsuka America Pharmaceutical, Inc. | 1 | $137 |
| Incyte Corporation | 1 | $130 |
| Alexion Pharmaceuticals, Inc. | 1 | $125 |
| BeOne Medicines USA, Inc. | 1 | $121 |
| AstraZeneca Pharmaceuticals LP | 1 | $111 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $85 |
| SANOFI-AVENTIS U.S. LLC | 1 | $43 |
Products named: CAPLYTA, REXULTI, Jakafi, ULTOMIRIS, BRUKINSA, LOKELMA, KISUNLA, ZEPBOUND.
Industry payments across GA — which companies pay providers there.
